MedPath
TGA Approval

CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen (374373)

374373

CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen

Cipla Australia Pty Ltd

September 6, 2022

Medicine

Medicine

Active

Registered

Active Ingredients

Adalimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CIPTUNEC adalimumab 40 mg/0.4 mL solution for subcutaneous injection pre-filled pen (374373) - TGA 批准文号 | MedPath